植物由来ワクチンの世界市場レポート 2024

植物由来ワクチンの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.4%の年間複合成長率（CAGR）で25億米ドルに成長すると予想されます。予測期間で予想される成長は、パンデミックへの備えの重視の高まり、世界の健康安全保障への懸念、ワクチン適用の拡大、製薬業界による植物由来ワクチンの採用などの要因に起因すると考えられます。予測期間に予想される主な動向には、植物バイオテクノロジーの技術進歩、ワクチン生産における環境持続可能性への焦点、ワクチン開発プロセスにおける人工知能（AI）と機械学習（ML）テクノロジーの統合などが含まれます。

植物由来ワクチン市場は、感染症の蔓延により大幅な成長が見込まれています。細菌、ウイルス、真菌、寄生虫などのさまざまな細菌によって引き起こされる感染症は、依然として世界の健康上の懸念です。 植物由来ワクチンは、さまざまな感染症の予防と治療のための、安全かつ効果的で手頃な価格のソリューションとして登場しました。たとえば、世界保健機関の2022年10月の世界結核報告書では、世界中で推定1,060万人の結核（TB）症例が報告されており、効果的なワクチン接種戦略の必要性が強調されています。したがって、植物由来ワクチン市場は、感染症の大きな負担に対処するという緊急の課題によって動かされています。

植物由来ワクチン市場の成長は、個別化医療への需要の高まりによってさらに加速されています。個人固有の遺伝子構造に基づいて治療を調整する個別化医療は、より効果的なヘルスケア介入のための顕著なアプローチとなっています。 植物由来ワクチンはこの個別化医療パラダイムに不可欠であり、より安全で効果的な免疫療法の可能性を提供します。個々の遺伝子プロファイルに基づいてワクチンの成分をカスタマイズできるため、治療の精度と有効性が向上します。 2022年に食品医薬品局の医薬品評価研究センターによって承認された新規分子実体（NME）の34％が個別化医療に分類されており、個別化医療の需要は植物由来ワクチン市場の主要な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の植物由来ワクチン市場、ワクチンタイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 細菌ワクチン
• ウイルスワクチン
• 寄生虫ワクチン
• その他のワクチンタイプ
• 世界の植物由来ワクチン市場、原料別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• タバコ植物
• トウモロコシ
• じゃがいも
• その他の情報源
• 世界の植物由来ワクチン市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• インフルエンザ
• ジカウイルス
• エボラウイルス
• 家禽の病気
• その他の用途

第7章 地域および国の分析

• 世界の植物由来ワクチン市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の植物由来ワクチン市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 植物由来ワクチン市場の競合情勢
• 植物由来ワクチン市場の企業プロファイル
  • Sanofi Pasteur SA
  • GlaxoSmithKline plc.
  • British American Tobacco PLC
  • ICON Plc.
  • Agenus Inc.

第31章 その他の大手および革新的な企業

• Medicago Inc.
• Panacea Biotec Limited
• Creative Biolabs Inc.
• InVitria
• Fraunhofer USA Inc.
• Biodextris Inc.
• Intravacc BV
• Avesthagen Limited
• Calyxt Inc.
• Zyus Life Sciences Inc.
• Mapp Biopharmaceutical Inc.
• Entos Pharmaceuticals Inc.
• Kentucky BioProcessing Inc.
• Planet Biotechnology Inc.
• Icon Genetics GmbH

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Plant-based vaccines are recombinant vaccines that utilize antigens against specific infections incorporated into selected plants. These vaccines offer an effective means of treating various human and animal diseases.

The primary types of plant-based vaccines include bacterial vaccines, viral vaccines, parasite vaccines, and others. Bacterial vaccines involve preparations of either dead or weakened bacteria utilized as active immunizing agents. Various plant sources, including tobacco plants, maize, and potatoes, are employed for this purpose. Plant-based vaccines find applications in addressing diseases such as influenza, Zika virus, Ebola virus, poultry diseases, and others.

The plant-based vaccines market research report is one of a series of new reports from The Business Research Company that provides plant-based vaccines market statistics, including plant-based vaccines industry global market size, regional shares, competitors with a plant-based vaccines market share, detailed plant-based vaccines market segments, market trends, and opportunities, and any further data you may need to thrive in the plant-based vaccines industry. This plant-based vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The plant-based vaccines market size has grown rapidly in recent years. It will grow from $1.52 billion in 2023 to $1.68 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth observed in the historical period can be attributed to several factors, including traditional challenges in vaccine production, the demand for cost-effective vaccine production methods, the emergence of plant molecular farming as an innovative approach, the potential for reduced allergenicity, and applications of synthetic biology in vaccine development.

The plant-based vaccines market size is expected to see rapid growth in the next few years. It will grow to $2.5 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period can be attributed to factors such as increased emphasis on pandemic preparedness, global health security concerns, the expansion of vaccine applications, and the adoption of plant-based vaccines by the pharmaceutical industry. Major trends expected in the forecast period include technological advancements in plant biotechnology, a focus on environmental sustainability in vaccine production, and the integration of artificial intelligence (AI) and machine learning (ML) technologies in vaccine development processes.

The plant-based vaccine market is expected to experience significant growth due to the high prevalence of infectious diseases. Infectious diseases, caused by various germs such as bacteria, viruses, fungi, or parasites, remain a global health concern. Plant-based vaccines have emerged as secure, effective, and affordable solutions for preventing and treating various infectious diseases. For example, the World Health Organization's Global Tuberculosis Report in October 2022 revealed an estimated 10.6 million cases of tuberculosis (TB) globally, emphasizing the need for effective vaccination strategies. The plant-based vaccine market is thus being driven by the imperative to address the substantial burden of infectious diseases.

The growth of the plant-based vaccine market is further fueled by the rising demand for personalized medicine. Personalized medicine, which tailors medical treatments based on an individual's unique genetic makeup, has become a prominent approach for more effective healthcare interventions. Plant-based vaccines are integral to this personalized medicine paradigm, offering the potential for safer and more effective immunotherapies. The ability to customize vaccine components based on individual genetic profiles enhances the precision and efficacy of treatments. With 34% of new molecular entities (NMEs) approved by the Food and Drug Administration's Center for Drug Evaluation and Research in 2022 classified as personalized medicines, the demand for personalized medicine is a key driver for the plant-based vaccine market.

Government funding for vaccine development is a significant factor propelling the growth of the plant-based vaccine market. Governments worldwide are investing in vaccine development to address various health challenges, including the COVID-19 pandemic. Funding initiatives support the research, development, and production of vaccines, including plant-based options. An example is the U.S. Department of Health and Human Services introducing a $350 million initiative to enhance COVID-19 vaccine distribution, emphasizing the importance of government support in advancing vaccine development.

Product innovation is a notable trend in the plant-based vaccine market, with major companies focusing on developing groundbreaking products to maintain their market positions. In February 2022, Medicago Inc. and GSK PLC announced the approval of COVIFENZ, the first plant-based COVID-19 vaccine by Health Canada. COVIFENZ utilizes coronavirus-such as particle (CoVLP) technology, representing an innovative approach to vaccine development.

Companies in the plant-based vaccine market are also adopting advanced solutions such as plant-technology platforms to optimize scalability, enhance efficacy, and streamline manufacturing processes. Utilizing plant systems for efficient vaccine production and development, British American Tobacco launched KBio Holdings Limited (KBio) in January 2022. KBio aims to leverage its plant-based technology platform to expedite research, development, and production of novel treatments for rare and infectious diseases, showcasing the potential of plant-based production systems in terms of speed, scale-up capability, and thermostability.

Major companies operating in the plant-based vaccines market report are Sanofi Pasteur SA, GlaxoSmithKline plc., British American Tobacco PLC, ICON Plc., Agenus Inc., Medicago Inc., Panacea Biotec Limited, Creative Biolabs Inc., InVitria, Fraunhofer USA Inc., Biodextris Inc., Intravacc B.V, Avesthagen Limited, Calyxt Inc., Zyus Life Sciences Inc., Mapp Biopharmaceutical Inc., Entos Pharmaceuticals Inc., Kentucky BioProcessing Inc., Planet Biotechnology Inc., Icon Genetics GmbH, PlantForm Corporation, LenioBio GmbH, Synbiotic Health Inc., Altimmune Inc., Oramed Pharmaceuticals Inc., iBio Inc., Lumen Bioscience Inc., Baiya Phytopharm Co. Ltd., Greenovation Biotech GmbH, Pevion Biotech AG

North America was the largest region in the plant-based vaccines market in 2023. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the plant-based vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The plant-based vaccines market consists of sales of cholera vaccines and norovirus vaccines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plant-Based Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plant-based vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plant-based vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plant-based vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Vaccine Type: Bacterial Vaccines; Viral Vaccines; Parasite Vaccines; Other Vaccine Types
• 2) By Source: Tobacco Plant; Maize; Potato; Other Sources
• 3) By Application: Influenza; Zika Virus; Ebola Virus; Poultry Disease; Other Applications
• Companies Mentioned: Sanofi Pasteur SA; GlaxoSmithKline plc.; British American Tobacco PLC; ICON Plc.; Agenus Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Plant-Based Vaccines Market Characteristics

3. Plant-Based Vaccines Market Trends And Strategies

4. Plant-Based Vaccines Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Plant-Based Vaccines Market Size and Growth

• 5.1. Global Plant-Based Vaccines Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Plant-Based Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Plant-Based Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Plant-Based Vaccines Market Segmentation

• 6.1. Global Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Bacterial Vaccines
• Viral Vaccines
• Parasite Vaccines
• Other Vaccine Types
• 6.2. Global Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Tobacco Plant
• Maize
• Potato
• Other Sources
• 6.3. Global Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Influenza
• Zika Virus
• Ebola Virus
• Poultry Disease
• Other Applications

7. Plant-Based Vaccines Market Regional And Country Analysis

• 7.1. Global Plant-Based Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Plant-Based Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Plant-Based Vaccines Market

• 8.1. Asia-Pacific Plant-Based Vaccines Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Plant-Based Vaccines Market

• 9.1. China Plant-Based Vaccines Market Overview
• 9.2. China Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Plant-Based Vaccines Market

• 10.1. India Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Plant-Based Vaccines Market

• 11.1. Japan Plant-Based Vaccines Market Overview
• 11.2. Japan Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Plant-Based Vaccines Market

• 12.1. Australia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Plant-Based Vaccines Market

• 13.1. Indonesia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Plant-Based Vaccines Market

• 14.1. South Korea Plant-Based Vaccines Market Overview
• 14.2. South Korea Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Plant-Based Vaccines Market

• 15.1. Western Europe Plant-Based Vaccines Market Overview
• 15.2. Western Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Plant-Based Vaccines Market

• 16.1. UK Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Plant-Based Vaccines Market

• 17.1. Germany Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Plant-Based Vaccines Market

• 18.1. France Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Plant-Based Vaccines Market

• 19.1. Italy Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Plant-Based Vaccines Market

• 20.1. Spain Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Plant-Based Vaccines Market

• 21.1. Eastern Europe Plant-Based Vaccines Market Overview
• 21.2. Eastern Europe Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Plant-Based Vaccines Market

• 22.1. Russia Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Plant-Based Vaccines Market

• 23.1. North America Plant-Based Vaccines Market Overview
• 23.2. North America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Plant-Based Vaccines Market

• 24.1. USA Plant-Based Vaccines Market Overview
• 24.2. USA Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Plant-Based Vaccines Market

• 25.1. Canada Plant-Based Vaccines Market Overview
• 25.2. Canada Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Plant-Based Vaccines Market

• 26.1. South America Plant-Based Vaccines Market Overview
• 26.2. South America Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Plant-Based Vaccines Market

• 27.1. Brazil Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Plant-Based Vaccines Market

• 28.1. Middle East Plant-Based Vaccines Market Overview
• 28.2. Middle East Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Plant-Based Vaccines Market

• 29.1. Africa Plant-Based Vaccines Market Overview
• 29.2. Africa Plant-Based Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Plant-Based Vaccines Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Plant-Based Vaccines Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Plant-Based Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Plant-Based Vaccines Market Competitive Landscape
• 30.2. Plant-Based Vaccines Market Company Profiles
  • 30.2.1. Sanofi Pasteur SA
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. GlaxoSmithKline plc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. British American Tobacco PLC
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. ICON Plc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Agenus Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Plant-Based Vaccines Market Other Major And Innovative Companies

• 31.1. Medicago Inc.
• 31.2. Panacea Biotec Limited
• 31.3. Creative Biolabs Inc.
• 31.4. InVitria
• 31.5. Fraunhofer USA Inc.
• 31.6. Biodextris Inc.
• 31.7. Intravacc B.V
• 31.8. Avesthagen Limited
• 31.9. Calyxt Inc.
• 31.10. Zyus Life Sciences Inc.
• 31.11. Mapp Biopharmaceutical Inc.
• 31.12. Entos Pharmaceuticals Inc.
• 31.13. Kentucky BioProcessing Inc.
• 31.14. Planet Biotechnology Inc.
• 31.15. Icon Genetics GmbH

32. Global Plant-Based Vaccines Market Competitive Benchmarking

33. Global Plant-Based Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Plant-Based Vaccines Market

35. Plant-Based Vaccines Market Future Outlook and Potential Analysis

• 35.1 Plant-Based Vaccines Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Plant-Based Vaccines Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Plant-Based Vaccines Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer